Business Description
Raffles Medical Group Ltd
ISIN : SG1CH4000003
Share Class Description:
SGX:BSL: Ordinary SharesDescription
Raffles Medical Group Ltd is an integrated private healthcare provider in Asia with operations in Singapore, China, Japan, Vietnam, and Cambodia. The company owns and operates a tertiary hospital, a network of medical and dental clinics, insurance services, Japanese and Traditional Chinese Medicine clinics, and a consumer healthcare division. The company's operating segment includes Healthcare services, Hospital Services, Investment Holdings, and Insurance Services. The company generates revenue from contracts with customers, Rental Income, and Insurance revenue.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 3.04 | |||||
| Equity-to-Asset | 0.67 | |||||
| Debt-to-Equity | 0.1 | |||||
| Debt-to-EBITDA | 0.8 | |||||
| Interest Coverage | 11.27 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 3.34 | |||||
| Beneish M-Score | -3.29 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 6.9 | |||||
| 3-Year EBITDA Growth Rate | 9 | |||||
| 3-Year EPS without NRI Growth Rate | 9.1 | |||||
| 3-Year FCF Growth Rate | 33.3 | |||||
| 3-Year Book Growth Rate | 4.7 | |||||
| Future 3-5Y Total Revenue Growth Rate | 5.13 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 61.29 | |||||
| 9-Day RSI | 50.92 | |||||
| 14-Day RSI | 46.97 | |||||
| 6-1 Month Momentum % | -14.08 | |||||
| 12-1 Month Momentum % | -15.71 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.2 | |||||
| Quick Ratio | 1.17 | |||||
| Cash Ratio | 0.8 | |||||
| Days Inventory | 17.93 | |||||
| Days Sales Outstanding | 56.2 | |||||
| Days Payable | 332.73 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.81 | |||||
| Dividend Payout Ratio | 0.75 | |||||
| 3-Year Dividend Growth Rate | 15 | |||||
| Forward Dividend Yield % | 2.81 | |||||
| 5-Year Yield-on-Cost % | 3.39 | |||||
| 3-Year Average Share Buyback Ratio | 0.1 | |||||
| Shareholder Yield % | 2.07 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 64.33 | |||||
| Operating Margin % | 10.48 | |||||
| Net Margin % | 8.68 | |||||
| FCF Margin % | 10.28 | |||||
| ROE % | 6.01 | |||||
| ROA % | 4 | |||||
| ROIC % | 4.58 | |||||
| ROC (Joel Greenblatt) % | 12.12 | |||||
| ROCE % | 8.08 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 27.19 | |||||
| Forward PE Ratio | 21.63 | |||||
| PE Ratio without NRI | 27.19 | |||||
| Shiller PE Ratio | 16.78 | |||||
| Price-to-Owner-Earnings | 7.54 | |||||
| PEG Ratio | 1.91 | |||||
| PS Ratio | 2.33 | |||||
| PB Ratio | 1.59 | |||||
| Price-to-Tangible-Book | 1.61 | |||||
| Price-to-Free-Cash-Flow | 22.31 | |||||
| Price-to-Operating-Cash-Flow | 16.73 | |||||
| EV-to-EBIT | 15.44 | |||||
| EV-to-Forward-EBIT | 14.9 | |||||
| EV-to-EBITDA | 10.8 | |||||
| EV-to-Forward-EBITDA | 10.43 | |||||
| EV-to-Revenue | 2 | |||||
| EV-to-Forward-Revenue | 1.86 | |||||
| EV-to-FCF | 19.2 | |||||
| Price-to-Projected-FCF | 0.78 | |||||
| Price-to-Median-PS-Value | 0.56 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.28 | |||||
| Price-to-Graham-Number | 1.4 | |||||
| Earnings Yield (Greenblatt) % | 6.47 | |||||
| FCF Yield % | 4.47 | |||||
| Forward Rate of Return (Yacktman) % | 20.37 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Raffles Medical Group Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil S$) | 701.858 | ||
| EPS (TTM) (S$) | 0.032 | ||
| Beta | 0.28 | ||
| Volatility % | 13.84 | ||
| 14-Day RSI | 46.97 | ||
| 14-Day ATR (S$) | 0.012701 | ||
| 20-Day SMA (S$) | 0.8725 | ||
| 12-1 Month Momentum % | -15.71 | ||
| 52-Week Range (S$) | 0.85 - 1.1 | ||
| Shares Outstanding (Mil) | 1,858.1 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Raffles Medical Group Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Raffles Medical Group Ltd Stock Events
| Event | Date | Price(S$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Raffles Medical Group Ltd Frequently Asked Questions
What is Raffles Medical Group Ltd(SGX:BSL)'s stock price today?
The current price of SGX:BSL is S$0.87. The 52 week high of SGX:BSL is S$1.10 and 52 week low is S$0.85.
When is next earnings date of Raffles Medical Group Ltd(SGX:BSL)?
The next earnings date of Raffles Medical Group Ltd(SGX:BSL) is .
Does Raffles Medical Group Ltd(SGX:BSL) pay dividends? If so, how much?
The Dividend Yield %  of Raffles Medical Group Ltd(SGX:BSL) is 2.81% (As of Today), Highest Dividend Payout Ratio of Raffles Medical Group Ltd(SGX:BSL) was 0.79. The lowest was 0.21. And the median was 0.5. The  Forward Dividend Yield % of Raffles Medical Group Ltd(SGX:BSL) is 2.81%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers